Bacterial Infection

Infectious Disease·MeSH: Bacterial Infections

17 drugs in development·13 companies·1 clinical trial

Drug Pipeline by Phase

Approved(7)

Drug	Company
azithromycin	GT Biopharma, Inc. (GTBP)
clarithromycin	SUNSET ISLAND GROUP (SUN)
compound honeysuckle granules	Fuss Brands Corp. (FBDS)
metronidazole in plastic container	Amneal Pharmaceuticals, Inc. (AMRX)
Roxithromycin Dispersible Tablets	CHINA PHARMA HOLDINGS, INC. (CPHI)
tobramycin	Amneal Pharmaceuticals, Inc. (AMRX)
Zerbaxa	Merck & Co., Inc. (MRK)

Phase 3(1)

Drug	Company
nuzyra	Paratek Pharmaceuticals, Inc. (PRTK)

Phase 2(5)

Drug	Company
oritavancin	TG THERAPEUTICS, INC. (TGTX)
part a	PFIZER INC (PFE)
part b	PFIZER INC (PFE)
spr206	Spero Therapeutics, Inc. (SPRO)
vabomere	MELINTA THERAPEUTICS, INC. /NEW/ (MLNT)

Phase 1(3)

Drug	Company
c-scape	Achaogen, Inc. (AKAO)
omadacycline	Paratek Pharmaceuticals, Inc. (PRTK)
omadacycline injection [nuzyra]	Paratek Pharmaceuticals, Inc. (PRTK)

Preclinical(1)

Drug	Company
tellurium based compounds	Qrons Inc. (QRON)

BioSniper tracks 17 drugs in development for Bacterial Infection across 13 companies.

There are 1 clinical trial targeting Bacterial Infection tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.